May 2, 2019
BD receives FDA approval for sterile CHG skin prep solution
Editor's Note
Becton, Dickinson and Company (BD) announced on April 30 that it had received Food & Drug Administration (FDA) approval for BD ChloraPrep skin preparation with sterile solution.
This new product is the only fully sterile chlorhexidine gluconate (CHG) antiseptic skin preparation commercially available in the US.
The FDA’s approval ensures the solution inside the applicator receives the same level of sterilization as the applicator, BD says.
Free Daily News
- Suicide Prevention Month: Hospitals prepare for new The Joint Commission suicide prevention goal, effective 2026
- Survey: Perioperative leaders adapt to supply strain, staffing pressure, ASC growth
- Gait retraining eases knee osteoarthritis pain as effectively as medication, can delay knee surgery
- OR leaders must sharpen questions, partnerships as AI reshapes perioperative care
- npj Digital Surgery opens call for research on AI, robotics in the OR
- AI in the OR can sharpen skills, but humans make the lessons stick
- Endoscopy case highlights risks of complex patients in ASCs
- Robotics and AI are redefining precision in cataract surgery
- CMS plan to phase out inpatient only list sparks debate over safety for vulnerable patients
- ACS issues new best practices for managing genitourinary trauma
© Access Intelligence, LLC. All rights reserved. |
Privacy Policy |
Cookie Settings |
Diversity, Equity, Inclusion & Belonging |
Accessibility Statement